NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Giraffe Bio

Giraffe Bio

Private
Buenos AiresFrontier & Industrial Techhttps://www.giraffe-bio.com/

Last Round

Seed

Oct 16, 2025

Total Funding Raised

$1.14M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Giraffe Bio is a biotechnology company that uses AI and custom-engineered biomolecules to optimize metal extraction, increase yield, and reduce environmental impact for the mining industry.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Circular Economy, Clean Manufacturing, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Hardware Sales

AI Layer

Application

Keywords

biominingmetal extractioncustom biomoleculesAI biomolecule designmining techmetal recoverybioleachingsustainable mininglow-grade ore processingmining waste reprocessingdrop-in solutioncell-free systembiochipscopper extractionlithium extraction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Giraffe Bio Comps

Public and private peers based on sector, stage, and business model.

Giraffe Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Giraffe Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 16, 2025

Key People

Founding team and executive leadership

Alejandro Buffo Sempé

Co-founder and CEO

Founding Team

Giraffe Bio Investors

Notable investors and investment history

Giraffe Bio investors
InvestorRounds
Start-Up ChileSeed
AIR CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 16, 2025

    $1.13M round led by AIR Capital and Columbia Business School.

  • Jul 18, 2025

    Grew 133% QoQ from 3 to 7 employees.

Giraffe Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Giraffe Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Giraffe Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBuenos Aires
Employee Range8
Year Founded2024
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.